
Rossland Pharmaceuticals Private Limited
About Rossland Pharmaceuticals Private Limited
Data last updated:
Rossland Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. The company is currently under liquidation, meaning its assets are being sold to settle outstanding debts. It may not have the legal capacity to fulfil new contracts. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 October 1993.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1993PTC055676.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹4.9 Lakh. It is led by directors Jagdip Singh Binepal and Harpreet Binepal.
Its last annual general meeting (AGM) was held on 22 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at C – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020.
As per the financials filed for FY 2026, the company reported a revenue of ₹7.02 Lakh, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹33,312 (net margin 4.7%) and EBITDA of ₹1.35 Lakh (EBITDA margin 19.2%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 18% over five years.
As per MCA filings, the company has satisfied charges of ₹8.21 Cr on record.
Company details
Contact details
Rossland Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Rossland Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Rossland Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Rossland Pharmaceuticals Private Limited, buy the company report.
Financials of Rossland Pharmaceuticals Private Limited
FY 2026 filings availableRossland Pharmaceuticals Private Limited reported revenue of ₹7.02 Lakh (up 14% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 14% growth in the latest year. EBITDA rose 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹7.02 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33,312 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 19.2% | ||||
| Net Profit Margin | 4.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rossland Pharmaceuticals Private Limited, buy the company report.
Board of directors of Rossland Pharmaceuticals Private Limited
Rossland Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jagdip Singh Binepal Also directs: Avitron Components Private Limited | Director | 14 Aug 1995 | 31 Years 3 Months | As last reported |
| Harpreet Binepal Also directs: Avitron Components Private Limited | Director | 14 Aug 1995 | 31 Years 3 Months | As last reported |
Auditor
Rossland Pharmaceuticals Private Limited is audited by S K GROVER & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S K GROVER & ASSOCIATES | FY 2021 | 005218N |
Shareholding
The shareholding of Rossland Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rossland Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Mar 2011 | 10282589 | Hdfc Bank Limited | ₹4.21 Cr | Satisfied | |
| 29 Jan 2005 | 80001997 | Syndicate Bank | ₹1.05 Cr | Satisfied | |
| 06 Nov 2003 | 80001998 | Syndicate Bank | ₹2.94 Cr | Satisfied |
To see the full charge records of Rossland Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
No court or tribunal cases involving Rossland Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rossland Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Rossland Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Rossland Pharmaceuticals Private Limited has 2 board changes on record since 1995: 2 appointments. The latest: Harpreet Binepal was appointed as Director on 14 Aug 1995.
1 earlier event is in the company report.
Frequently asked questions
Rossland Pharmaceuticals is currently "Under Liquidation" as per MCA records. The company's assets are being sold to settle outstanding debts owed to creditors. A company under liquidation may not have the legal capacity to fulfil new contracts, and creditors are prioritised in the distribution of proceeds. This is a high-risk status - caution is strongly advised.
Rossland Pharmaceuticals is a company under liquidation, formerly operating as a private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 October 1993 and is registered under CIN U74899DL1993PTC055676. Caution is advised - the company may not have the legal capacity to fulfil new agreements.
Rossland Pharmaceuticals has 2 current directors:
- Jagdip Singh Binepal - Director
- Harpreet Binepal - Director
The latest financial statements of Rossland Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 22 June 2026. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Rossland Pharmaceuticals is U74899DL1993PTC055676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rossland Pharmaceuticals has no open charges and satisfied charges of ₹8.21 Cr as per latest MCA filings.
Rossland Pharmaceuticals was incorporated on 18 October 1993. It is registered with the Registrar of Companies, Delhi.
Harpreet Binepal was appointed as Director on 14 Aug 1995. Jagdip Singh Binepal was appointed as Director on 14 Aug 1995.
The registered office of Rossland Pharmaceuticals is at C – 35 Dda Sheds Okhla Phase – V, New Delhi, Delhi, India – 110020.
Rossland Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.

